Atlas Trials

Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients

Clinical trial NCT03168308 · COMPLETED

Trial details

NCT number
NCT03168308
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Neuromuscular Blockade
Start date
2017-09-26
Primary completion
2019-09-30
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.